Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.

INSIGHT START Study Group, Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, Avihingsanon A, Cooper DA, Fätkenheuer G, Llibre JM, Molina JM, Munderi P, Schechter M, Wood R, Klingman KL, Collins S, Lane HC, Phillips AN, Neaton JD.

N Engl J Med. 2015 Aug 27;373(9):795-807. doi: 10.1056/NEJMoa1506816. Epub 2015 Jul 20.

2.

Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.

INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD.

HIV Med. 2015 Apr;16 Suppl 1:1-9. doi: 10.1111/hiv.12227. No abstract available.

3.

[Alliance against MDRO: safeguarding antibiotics].

Carlet J, Rambaud C, Pulcini C; l'Alliance contre développement des bactéries multirésistantes (ACdeBMR).

Ann Fr Anesth Reanim. 2012 Sep;31(9):704-8. doi: 10.1016/j.annfar.2012.07.003. Epub 2012 Aug 24. French.

PMID:
22925945
4.

Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings.

Calmy A, Balestre E, Bonnet F, Boulle A, Sprinz E, Wood R, Delaporte E, Messou E, McIntyre J, El Filali KM, Schechter M, Kumarasamy N, Bangsberg D, McPhail P, Van Der Borght S, Zala C, Egger M, Thiébaut R, Dabis F; T-LINC of IeDEA Collaboration (Asia, South America, East, Southern and West Africa).

BMC Infect Dis. 2012 Jun 28;12:147. doi: 10.1186/1471-2334-12-147.

5.

[Causes of death among 91 HIV-infected adults in the era of potent antiretroviral therapy].

Sodqi M, Marih L, Lahsen AO, Bensghir R, Chakib A, Himmich H, El Filali KM.

Presse Med. 2012 Jul;41(7-8):e386-90. doi: 10.1016/j.lpm.2011.12.013. Epub 2012 Feb 18. French.

PMID:
22350063
6.

[Pulmonary aspergillosis and HIV infection: about two cases].

El Fane M, Ouladlahsen A, Bakhatar A, Sodqi M, El Filali KM, Bahlaoui A, Chakib A.

Rev Pneumol Clin. 2012 Feb;68(1):36-9. doi: 10.1016/j.pneumo.2011.05.005. Epub 2011 Nov 6. French.

PMID:
22056792
7.

Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT).

Pett SL, Carey C, Lin E, Wentworth D, Lazovski J, Miró JM, Gordin F, Angus B, Rodriguez-Barradas M, Rubio R, Tambussi G, Cooper DA, Emery S; INSIGHT-ESPRIT Study Group.

HIV Med. 2011 Apr;12(4):219-27. doi: 10.1111/j.1468-1293.2010.00875.x. Epub 2010 Aug 31.

8.

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA; ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA); CEPAC International investigators.

PLoS Med. 2009 Oct;6(10):e1000173. doi: 10.1371/journal.pmed.1000173. Epub 2009 Oct 27.

9.

Interleukin-2 therapy in patients with HIV infection.

INSIGHT-ESPRIT Study Group; SILCAAT Scientific Committee, Abrams D, Lévy Y, Losso MH, Babiker A, Collins G, Cooper DA, Darbyshire J, Emery S, Fox L, Gordin F, Lane HC, Lundgren JD, Mitsuyasu R, Neaton JD, Phillips A, Routy JP, Tambussi G, Wentworth D.

N Engl J Med. 2009 Oct 15;361(16):1548-59. doi: 10.1056/NEJMoa0903175.

10.

Interruption of antiretroviral therapy is associated with increased plasma cystatin C.

Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, Tracy R, Kuller L, Shlipak M, Angus B, Klinker H, Ross M; INSIGHT SMART Study Group.

AIDS. 2009 Jan 2;23(1):71-82. doi: 10.1097/QAD.0b013e32831cc129.

11.

Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaboration.

Braitstein P, Boulle A, Nash D, Brinkhof MW, Dabis F, Laurent C, Schechter M, Tuboi SH, Sprinz E, Miotti P, Hosseinipour M, May M, Egger M, Bangsberg DR, Low N; Antiretroviral Therapy in Lower Income Countries (ART-LINC) study group.

J Womens Health (Larchmt). 2008 Jan-Feb;17(1):47-55. doi: 10.1089/jwh.2007.0353.

PMID:
18240981
12.

[Effectiveness and tolerance of amoxicillin/clavulanic acid ("Augmentin") in intravenous injections in adults].

el Filali KM, el M'Daghri N, el Kabli H, Hajji M, Benbachir M, Himmich H.

Pharmatherapeutica. 1989;5(5):329-37. French.

PMID:
2748691
13.

Prospective randomized comparative trial of pefloxacin versus cotrimoxazole in the treatment of typhoid fever in adults.

Hajji M, el Mdaghri N, Benbachir M, el Filali KM, Himmich H.

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):361-3.

PMID:
3137036

Supplemental Content

Loading ...
Support Center